A biofilm activator MmtA1 modulates multi-drug resistance in mycobacteria
The paper investigates how Mycobacterium species form antibiotic-induced biofilms and multidrug resistance, focusing on the transcriptional factor MmtA1 and its response to the anti-tuberculosis drug isoniazid. Using M. smegmatis, the authors report that MmtA1 regulates genes involved in sugar and lipid transportation, and that this regulatory activity increases biofilm formation and multidrug resistance after isoniazid exposure. A key caveat is that the study characterizes these mechanisms in a model mycobacterium (M. smegmatis) rather than directly in Mycobacterium tuberculosis or in human disease tissue. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,271 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-05-29T02:00:03.542394+00:00